DTx Clinical Trials:
Interoperability and the Power of Remote Trial Designs

Kimberly Tableman is Chief Clinical Development Officer (CCDO) at Castor. She has more than 23 years of experience in clinical development and technology. Over the past decade, she has focused on applying digital health technologies to reimagine the patient journey. She was most recently CEO at Medicine X, and co-founder at Rabble Health, where she led the development and beta launch of a patient engagement platform to serve oncology patients. Prior to Medicine X, Kimberly held senior roles at GlaxoSmithKline (GSK), including Head of Patient Engagement and Head of Digital Clinical Trials. She has also worked at Pfizer, and began her career in management consulting at Cap Gemini Ernst & Young.

Dr. Taylor is Head of Clinical Trials at MedRhythms, a leading next-generation digital therapeutics company. She has more than 10 years of experience in research, with expertise in clinical trial project management. Prior to MedRhythms, she was Director of Clinical Studies at the University of California San Francisco Brain and Spinal Injury Center (BASIC). There, she maintained a clinical research trial network of more than 20 clinical trial sites, all Level 1 trauma centers, for several national, multicenter clinical research initiatives, including the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) network. Sabrina was also a Research Coordinator in the Neurorehabilitation Laboratory at Spaulding Rehabilitation Hospital, one of the nation’s top rehabilitation centers, where she coordinated the Traumatic Brain Injury Model System (TBIMS) and other projects. She received her B.S. in Neuroscience at Stonehill College and her Ph.D. in Experimental and Molecular Medicine (Neuroscience) at Dartmouth College.